Varicella disease after introduction of varicella vaccine in the United States, 1995-2000
about
sameAs
The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003Herpes zoster in Germany: quantifying the burden of diseaseClade, Country and Region-specific HIV-1 Vaccines: Are they necessary?Microbiology laboratory and the management of mother-child varicella-zoster virus infectionReview of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project dataUniversal varicella vaccination: efficacy trends and effect on herpes zosterVaricella vaccinesHerpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United StatesGenome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factorImmediate and longer term impact of the varicella shortage on children 18 and 24 months of age in a community population.Immunogenicity and safety of concomitant administration of a measles, mumps and rubella vaccine (M-M-RvaxPro) and a varicella vaccine (VARIVAX) by intramuscular or subcutaneous routes at separate injection sites: a randomised clinical trial.Varicella vaccination in Europe - taking the practical approach.Varicella: epidemiological aspects and vaccination coverage in the Veneto Region.Varicella vaccination coverage of children under two years of age in GermanyPreventing varicella-zoster diseaseAn outbreak of varicella among schoolchildren in Taipei.Primary versus secondary failure after varicella vaccination: implications for interval between 2 dosesDecline in varicella-related ambulatory visits and hospitalizations in the United States since routine immunization against varicella.Varicella vaccination in England and Wales: cost-utility analysis.Predictors of cerebral arteriopathy in children with arterial ischemic stroke: results of the International Pediatric Stroke StudySuccesses and challenges in varicella vaccineThe controversy of varicella vaccination in children with acute lymphoblastic leukemia.Secular trends of chickenpox among military population in Israel in relation to introduction of varicella zoster vaccine 1979-2010.Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005.Forecasting dengue vaccine demand in disease endemic and non-endemic countries.Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries.Varicella vaccine update: need for a booster?Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccineImpact of 2-dose vaccination on varicella epidemiology: Connecticut--2005-2008Genotype of varicella-zoster virus isolates in South Korea.Declining incidence of chickenpox in the absence of universal childhood immunisationSystematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries.Safety of a second dose of varicella vaccine administered at 4 to 6 years of age in healthy children in Argentina.Chickenpox exposure and herpes zoster disease incidence in older adults in the U.S.Validity of self-reported varicella disease history in pregnant women attending prenatal clinics.Digital epidemiology reveals global childhood disease seasonality and the effects of immunization.Varicella-zoster vaccine in the USA: success for control of disease severity, but what next?Should the UK introduce varicella vaccine?Varicella disease in Beijing in the era of voluntary vaccination, 2007 to 2010.Impact of a routine two-dose varicella vaccination program on varicella epidemiology.
P2860
Q21257242-53C0693E-B904-4B96-B20A-BDB6BAEE7C3DQ21261833-6785F71C-425F-432F-AB2D-FEF7FB44D853Q24803275-07371E86-7B2A-444E-9C04-B9FC0CDA238FQ26738745-C234757C-20EC-446F-9A4E-BE84F82B838BQ26863614-405F23D1-0591-4FD2-867C-7047AD123AA0Q28269376-F2572899-0607-4723-A7EC-BDE06495C625Q28272397-3DEF44B8-079B-481B-9DC3-00965315A1BEQ28300462-B4415731-6F3C-4333-9D35-D0FA193DD24FQ28474768-3D0B4617-9EEB-4F1C-ABA9-A062F4DBA014Q33254082-8EBF368E-59BE-420E-B6C1-192997D009E1Q33430135-CD790A6E-670E-4137-84E0-50CD48BF318BQ33454919-4F1AE00B-9C2D-43B8-979A-AF84AE4DB0D0Q33500864-CA474646-7A53-4DD0-A1B6-A3125739C224Q33665393-24F105A3-40AF-4A21-84D9-75A639A97E2AQ33719386-5367D63D-0961-499E-9F12-D8A7973321B5Q33870506-0A1327F0-145A-4CCB-B492-5413FC91EEC1Q33880341-35CC951C-1814-42B8-BE11-B3719F0D63C0Q34074644-B4884429-F669-4F00-8B4C-32F3C80AF99BQ34263829-B8D43F84-3CED-40DE-9594-505BA48A34CEQ34385702-25930D07-574E-4F61-AA0D-00798CC376FBQ34416710-979BDA2F-AFB4-4F9A-88DA-6425DB241806Q34419709-6FADC370-F711-42C2-8640-1262596E5128Q34587972-D781C8D6-4EDE-4008-BFC3-86612CC98015Q34590637-E309E017-1DCB-4D99-AD90-B4A7F22081CAQ34663963-4DB44B4A-2557-4641-BD10-B92706D9FDA4Q34683751-ED4E7014-F282-49DF-8E38-C3262832E64AQ34733655-485A2E51-70E1-450B-B2CD-B2A4D842AAA2Q34763836-F0072F64-6B29-47D3-A73F-9EE6DCF2BAC1Q34764434-0516030D-B307-4309-8656-E50763C5D8B3Q35066632-74A16D61-831E-42A1-A22A-C47E2675540CQ35277040-8B62F81B-A038-4285-8E48-EAE929368CB0Q35652212-E780579B-6157-4AB1-ABC8-6DAEA2B3C857Q35667367-BF8AEAEB-A3E8-4975-B487-3C3F9DB24B0DQ35676115-67BAF6C9-D2CE-46AB-A930-C577904FE84FQ35836724-7CC6920D-D2CF-43AB-BB4E-3C38CBBDAE88Q36035946-C144EAAC-9BBC-4F9D-BE9E-CA1561FC4CB6Q36066227-F28912FC-2137-46CC-BF4B-DCE2FA831475Q36121450-59DE3671-3606-4790-8A5E-A2F641582F8DQ36136682-DB13BA58-9887-4755-8698-E468110EED4EQ36206514-110D8D03-8BB8-4E0D-88DB-473E6BF99233
P2860
Varicella disease after introduction of varicella vaccine in the United States, 1995-2000
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Varicella disease after introduction of varicella vaccine in the United States, 1995-2000
@ast
Varicella disease after introduction of varicella vaccine in the United States, 1995-2000
@en
Varicella disease after introduction of varicella vaccine in the United States, 1995-2000
@nl
type
label
Varicella disease after introduction of varicella vaccine in the United States, 1995-2000
@ast
Varicella disease after introduction of varicella vaccine in the United States, 1995-2000
@en
Varicella disease after introduction of varicella vaccine in the United States, 1995-2000
@nl
prefLabel
Varicella disease after introduction of varicella vaccine in the United States, 1995-2000
@ast
Varicella disease after introduction of varicella vaccine in the United States, 1995-2000
@en
Varicella disease after introduction of varicella vaccine in the United States, 1995-2000
@nl
P2093
P356
P1476
Varicella disease after introduction of varicella vaccine in the United States, 1995-2000
@en
P2093
Aisha O Jumaan
Barbara M Watson
Carol L Peterson
Gary S Goldman
Jan W Pelosi
Jane F Seward
John X Zhang
Kimberly G Brodovicz
Laura J Tabony
Laurene Mascola
P304
P356
10.1001/JAMA.287.5.606
P407
P577
2002-02-06T00:00:00Z